16-17 Nov, London - Lipids and Health: Risk, Reward and Revelation

Registration and refreshments

Session 1: Risk 1

Saturated fatty acids: friends or foes?
Prof Philippe Legrand, Head of Biochemistry Laboratory, Agrocampus Ouest, France

Different types of dietary fat and risk of heart disease: evidence from human studies
Dr Peter L Zock, Unilever Research & Development, The Netherlands

Flash presentation: EJLST poster prize winner
Ms Ana Pinto, King’s College London, UK

Lunch, exhibition and poster session

Session 2: Risk 2

Fat soluble vitamin reduction in food processing
Dr Marc Pignitter, Department of Nutritional and Physiological Chemistry, University of Vienna, Austria

Should dietary fat guidelines have been introduced? 
Dr Zoe Harcombe, University of the West of Scotland, UK

Neuromuscular function and falls-related fragility fractures; does vitamin D have a role to play?
Dr Claire Minshull, Queen Margaret University, Edinburgh and University of Edinburgh, UK

Refreshment break, exhibition and poster session

Session 3: Reward 1

DHA and ARA – What do we know and what do we need to know?
Prof Stewart Forsyth, Honorary Professor, Dundee University, Scotland

Practical methods of determining the benefit of LC_PUFA’s to infant formulas
Dr Peter Willatts, School of Psychology, Dundee University, Scotland

A quantum mechanical theory on the role of docosahexaenoic acid in the evolution of neural signaling and brain function
Prof Michael Crawford, Reproductive Physiology, Chelsea and Westminster Hospital, Imperial College London, UK

Close

Wine reception

Conference dinner

Conference opening

Mary Enig memorial lecture - trans and sat fats - relative risks!
Mr Eric Enig, Enig Associates, USA

Session 4: Reward 2

The importance of arachidonic acid in brain development
Dr Rob Winwood, DSM Nutritional Products UK and chair of the GOED scientific committee, UK

Fatty acids and childrens' behaviour
Dr Alex Richardson, University of Oxford, UK and Food and Behaviour (FAB) Research Centre for Evidence Based Intervention, Oxford, UK

Refreshment break, exhibition and poster session

Session 5: Revelation 1

Influence of human genetic variation on the biosynthesis, metabolism and impact of polyunsaturated fatty acids
Dr Floyd ’Ski’ Chilton, Dept. of Physiology & Pharmacology, Wake Forest School of Medicine, USA

Manipulation of infant formula lipid composition to increase DHA levels in infants
Dr Bernadette Delplanque, The Paris-Saclay Institute of Neuroscience (Neuro-PSI), Université Paris Sud, France

Lunch, exhibition and poster session

Session 6: Revelation 2

The potential of omega-3 fatty acids for the treatment of brain and spinal cord injury
Dr Adina Michael-Titus, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK

Heterologous synthesis of omega-3 long chain polyunsaturated fatty acids in transgenic plants via iterative metabolic engineering: a terrestrial source of fish oils
Prof Jonathan Napier, Dept. of Biological Chemistry and Crop Protection, Rothamsted Research, UK

SCI Lipids Group Hilditch Memorial Lecture
How DHA could modulate cancer cell function
Dr Paola Corsetto, Dept. of Pharmacological and Biomolecular Science, University of Milan, Italy

Refreshment break, exhibition and poster session

Session 7: Revelation 3

Nirvana for Britain: healthy frying
Dr Parkash Kochhar, SCI, Lipids consultant and Oxford Brookes University, UK

Bioavailability of omega 3 fatty acids
Dr Rob Winwood, DSM Nutritional Products UK and chair of the GOED scientific committee, UK

A pragmatic approach to achieving a healthy lipid intake in the general population
Prof Jack Winkler, Emeritus Professor of Nutrition Policy, London Metropolitan University, UK

Conference review - have we rehabilitated healthy lipids?

Closing remarks